Answered

Explore Westonci.ca, the leading Q&A site where experts provide accurate and helpful answers to all your questions. Join our Q&A platform to connect with experts dedicated to providing precise answers to your questions in different areas. Get precise and detailed answers to your questions from a knowledgeable community of experts on our Q&A platform.

An IRB may suspend or terminate an ongoing clinical study if:

A. Subjects are not being enrolled quickly enough.
B. A drug being used in the trial is approved by the FDA.
C. Instructions from the IRB are not being followed.
D. The clinical trial sponsor conducts an audit at the site.

Sagot :

GinnyAnswer

Final answer:

IRBs protect the rights of clinical trial participants by ensuring informed consent and adherence to FDA regulations.


Explanation:

Institutional Review Boards (IRBs) play a critical role in protecting the rights, safety, and well-being of human subjects participating in clinical trials. IRBs ensure that volunteers give informed consent and that the study follows all ethical and regulatory guidelines outlined by the FDA.


Learn more about Institutional Review Boards (IRBs) in Clinical Trials here:

https://brainly.com/question/31579853


Thank you for trusting us with your questions. We're here to help you find accurate answers quickly and efficiently. Thanks for using our platform. We aim to provide accurate and up-to-date answers to all your queries. Come back soon. Westonci.ca is here to provide the answers you seek. Return often for more expert solutions.